Literature DB >> 12933891

Differential interleukin-8 and nitric oxide production in epithelial cells induced by mucosally invasive and noninvasive Trypanosoma cruzi trypomastigotes.

C S Eickhoff1, L Eckmann, D F Hoft.   

Abstract

Trypanosoma cruzi metacyclic trypomastigotes (MT), but not blood form trypomastigotes (BFT), are highly mucosally infective. We investigated the abilities of MT and BFT to induce inflammation and/or intracellular killing activity within mucosal epithelia. BFT, but not MT, induced marked increases in interleukin-8, GRO-alpha, MCP-1, and nitric oxide production in HeLa and AGS cells, despite similar infectivities. MT may avoid induction of inflammation as an important biological mechanism facilitating mucosal invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12933891      PMCID: PMC187333          DOI: 10.1128/IAI.71.9.5394-5397.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Expression of trans-sialidase and 85-kDa glycoprotein genes in Trypanosoma cruzi is differentially regulated at the post-transcriptional level by labile protein factors.

Authors:  G Abuin; L H Freitas-Junior; W Colli; M J Alves; S Schenkman
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

2.  Differential glycosylation of epitope-tagged glycoprotein Gp72 during the Trypanosoma cruzi life cycle.

Authors:  P A Haynes; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1996-12-20       Impact factor: 1.759

3.  Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages.

Authors:  M M Camargo; I C Almeida; M E Pereira; M A Ferguson; L R Travassos; R T Gazzinelli
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

4.  Protein synthesis in purified trypo- and epimastigote forms of Trypanosoma cruzi.

Authors:  S Astolfi Filho; M F De Sá; E S Gander
Journal:  Acta Trop       Date:  1984-06       Impact factor: 3.112

5.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

6.  Chemokine secretion of human cells in response to Toxoplasma gondii infection.

Authors:  C F Denney; L Eckmann; S L Reed
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

7.  Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses.

Authors:  D F Hoft; P L Farrar; K Kratz-Owens; D Shaffer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  Differential mucosal infectivity of different life stages of Trypanosoma cruzi.

Authors:  D F Hoft
Journal:  Am J Trop Med Hyg       Date:  1996-10       Impact factor: 2.345

9.  The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide.

Authors:  F Villalta; Y Zhang; K E Bibb; J C Kappes; M F Lima
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro.

Authors:  G N Vespa; F Q Cunha; J S Silva
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more
  2 in total

1.  Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.

Authors:  Nicole L Sullivan; Christopher S Eickhoff; John Sagartz; Daniel F Hoft
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

2.  Transcriptome profile of Trypanosoma cruzi-infected cells: simultaneous up- and down-regulation of proliferation inhibitors and promoters.

Authors:  Takako Shigihara; Muneaki Hashimoto; Noriko Shindo; Takashi Aoki
Journal:  Parasitol Res       Date:  2007-12-05       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.